Outlook Therapeutics OverviewOutlook Therapeutics Net Income
Profitability analysis for OTLK.
Quarterly Net Income
-$4453.08B
↑ 90.39% YoY
As of Mar 2026
Annual Net Income (TTM)
-$37898.38B
↑ 63.68% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...